Elizabeth Warren’s New Target: ‘Egregious’ Conflicts of Interest in Trump’s COVID-19 Response
“In a crisis with more than a hundred thousand Americans dead and tens of millions unemployed, White House decisions should be driven by science, rather than by personal profit,” Warren tells Rolling Stone
Sen. Elizabeth Warren (D-Mass.) is leading a group of Democratic lawmakers in an investigation of what they describe as “egregious” financial conflicts of interest in the Trump administration’s coronavirus response, citing top officials’ financial stake in companies involved with the all-important effort to find a COVID-19 vaccine.
In two new letters sent to the White House and the Department of Health and Human Services, the lawmakers singled out Dr. Moncef Slaoui, chief adviser to Operation Warp Speed, the administration’s breakneck effort to develop a COVID-19 vaccine or treatment, and Marc Short, chief of staff to Vice President Mike Pence, the leader of the White House Coronavirus Task Force. Both Slaoui and Short have key roles in the coronavirus response effort while holding stock in companies whose values could soar from the development of a COVID-19 vaccine, according to public reporting and financial disclosures.
The two letters — written by Sens. Warren and Richard Blumenthal (D-Conn.) and Rep. Pramila Jayapal (D-Wash.) — call on Dr. Slaoui and Short to comply with federal conflict-in-interest laws and, in Short’s case, respond to questions about any decision-making he has participated in that involved companies in which he has a financial stake....Read the full article on the Rolling Stone website here.
Read the full article on the Rolling Stone website here.
By: Andy Kroll
Source: Rolling Stone
Next Article Previous Article